Pembrolizumab and Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT03267888 · COMPLETED

Trial details

NCT number: NCT03267888
Sponsor: Emory University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

ISS Stage I Plasma Cell Myeloma ISS Stage II Plasma Cell Myeloma ISS Stage III Plasma Cell Myeloma Recurrent Plasma Cell Myeloma Refractory Plasma Cell Myeloma

Start date: 2018-05-29
Primary completion: 2022-09-02
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.